American Biogenetic Sciences Inc. said Friday that it has raised$10.3 million through the redemption of its 3.45 million class Awarrants. The warrants were exercised to buy for $3 one shareof common stock and one class B warrant. The B warrantsentitle holders to purchase for $4.50 one share of commonstock (NASDAQ:MABXA). American Biogenetic of Notre Dame,Ind., is developing monoclonal antibody-based products todiagnose, prevent and treat cardiovascular disease and todiagnose Alzheimer's disease. The stock closed at $7.63 Friday,down $1.25.
(c) 1997 American Health Consultants. All rights reserved.